1-4 of 4
Joseph Thaddeus Beck
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab Vedotin in Frontline Therapy of Hodgkin Lymphoma in Patients with Significant Comorbidities Ineligible for Standard Chemotherapy (SGN35-015 Part E)

Christopher Yasenchak, Rodolfo Bordoni, Dipti Patel-Donnelly, Timothy Larson, Jerome Goldschmidt, Ralph Boccia, Vivian J. M. Cline, Shweta Jain, Jingmin Liu, Joseph Thaddeus Beck
Journal: Blood
Blood (2023) 142 (Supplement 1): 4435.
https://doi.org/10.1182/blood-2023-190260
Published: 2023
Journal Articles

Trial in Progress: Phase 1b Bridging Study of the Pharmacokinetics (PK), Safety, and Efficacy of Orally Administered Olverembatinib (HQP1351) in Patients with Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph⁺ ALL)

Elias J. Jabbour, Hagop Kantarjian, Ghayas C. Issa, Joseph Thaddeus Beck, Rebecca B. Klisovic, Sudipto Mukherjee, Vivian G. Oehler, Zi Chen, Ming Lu, Tommy Fu, Lixin Jiang, Yifan Zhai, Dajun Yang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2551.
https://doi.org/10.1182/blood-2021-152693
Published: 2021
Journal Articles

Preliminary Results from a Phase 1/2, Open-Label, Dose-Escalation Clinical Trial of IMO-8400 in Patients with Relapsed or Refractory Waldenstrom's Macroglobulinemia

Sheeba K. Thomas, MD, Wael A. Harb, MD, Joseph Thaddeus Beck, MD, Gabrail Nashat, MD, M. Lia Palomba, MD, Stephen M Ansell, MD PhD, Herbert Eradat, MD, Edward N. Libby, III, MD, Ranjana H Advani, MD, Julio Hajdenberg, MD, Leonard T Heffner, MD, James Hoffman, MD, David H. Vesole, MD, Lindsey Simov, Nancy Wyant, Julie Brevard, MPH, James O'Leary, MD, Sudhir Agrawal, D.Phil
Journal: Blood
Blood (2015) 126 (23): 1540.
https://doi.org/10.1182/blood.V126.23.1540.1540
Published: 2015
Journal Articles

A Phase I/II Study of BHQ880, a Novel Osteoblat Activating, Anti-DKK1 Human Monoclonal Antibody, in Relapsed and Refractory Multiple Myeloma (MM) Patients Treated with Zoledronic Acid (Zol) and Anti-Myeloma Therapy (MM Tx).

Swaminathan Padmanabhan, MD, MBBS, Joseph Thaddeus Beck, MD, Kevin R. Kelly, MD, Nikhil C. Munshi, MD, Andy Dzik-Jurasz, Esha Gangolli, Seth Ettenberg, Kelly Miner, Sanela Bilic, Winston Whyte, Fazal Mehdi, Lu-May Chiang, Patricia Liz Rae, BSc, Andrew Spencer, Jatin Shah, MD, Kenneth C. Anderson, MD, Francis J. Giles, MB, MD, FRCPI, FRCPath, A. Keith Stewart, MBChB
Journal: Blood
Blood (2009) 114 (22): 750.
https://doi.org/10.1182/blood.V114.22.750.750
Published: 2009